Pulmonary pharmaceutical formulations
US8614255B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Aug 21, 2008 |
| Grant date | Dec 24, 2013 |
| Priority date | — |
| Expiry date | Feb 13, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P11/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides improved pharmaceutical formulations for pulmonary delivery having improved chemical and physical stability of the therapeutic, prophylactic or diagnostic agent as compared to formulations known in the art. The improved pharmaceutical formulations of the invention for administration to the respiratory system of a patient for the treatment of a variety of disease conditions comprise a mass of biocompatible particles comprising an active agent, and a hydrogenated starch hydrosylate (HSH). The improvement over the prior art comprises the presence of HSH in the pharmaceutical formulation. The invention further relates to a method of treating diseases comprising administering the pharmaceutical formulations of the present invention to the respiratory system of a patient in need of treatment.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.